- $466.45m
- $307.70m
- $97.42m
- 78
- 38
- 52
- 56
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 87.2 | 100 | 123 | 121 | 97.4 |
Cost of Revenue | |||||
Gross Profit | 77 | 89.6 | 106 | 105 | 85.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 89.1 | 101 | 119 | 117 | 111 |
Operating Profit | -1.92 | -0.763 | 3.51 | 3.9 | -13.5 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1.37 | 2.52 | 5.69 | 4.2 | -8.21 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.028 | -2.38 | 0.396 | -13.9 | -18.4 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 0.028 | -2.38 | 0.396 | -23.2 | -11.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.028 | -2.38 | 0.396 | -23.2 | -11.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.001 | -0.108 | 0.017 | -0.499 | -0.782 |